Alteplase exhibits specificity for fibrin, primarily targeting plasminogen and fibrin in the coagulation process, with relatively minimal impact on other biological molecules (pharmacokinetics of alteplase in treating ischemic stroke). Here, PLG is linked to ischemic stroke.